File Download

There are no files associated with this item.

Supplementary

Conference Paper: Tenofovir alafenamide (TAF) compared with Tenofovir Dispoproxil Fumarate (TDF) in patients with chronic HBV: week 96 efficacy and safety results in Chinese patients enrolled in 2 overseas phase 3 studies

TitleTenofovir alafenamide (TAF) compared with Tenofovir Dispoproxil Fumarate (TDF) in patients with chronic HBV: week 96 efficacy and safety results in Chinese patients enrolled in 2 overseas phase 3 studies
磷丙替诺福韦（TAF）和富马酸替诺福韦二吡呋酯（TDF）用于慢性HBV患者的疗效比较：纳入2项海外3期研究的华裔患者治疗96周的疗效
Authors
Seto, WKWFung, SHou, JPan, CChuang, WLChang, TTHui, AJChen, CYMa, XTam, ETsang, TYYang, JFlaherty, JFGaggar, AMo, STong, MKao, JHChan, HL
Issue Date2017
Citation
Chinese Infectious Disease and Hepatology Conference, Wuhan, China, 12-14 October 2017 How to Cite?
第十八次全国病毒性肝炎及肝病学术会议暨2017年中华医学会感染病学分会年会、中华医学会肝病学分会年会, 中国, 湖北省,武汉市, 2017年10月12-14日 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/253581

 

DC FieldValueLanguage
dc.contributor.authorSeto, WKW-
dc.contributor.authorFung, S-
dc.contributor.authorHou, J-
dc.contributor.authorPan, C-
dc.contributor.authorChuang, WL-
dc.contributor.authorChang, TT-
dc.contributor.authorHui, AJ-
dc.contributor.authorChen, CY-
dc.contributor.authorMa, X-
dc.contributor.authorTam, E-
dc.contributor.authorTsang, TY-
dc.contributor.authorYang, J-
dc.contributor.authorFlaherty, JF-
dc.contributor.authorGaggar, A-
dc.contributor.authorMo, S-
dc.contributor.authorTong, M-
dc.contributor.authorKao, JH-
dc.contributor.authorChan, HL-
dc.date.accessioned2018-05-21T02:59:56Z-
dc.date.available2018-05-21T02:59:56Z-
dc.date.issued2017-
dc.identifier.citationChinese Infectious Disease and Hepatology Conference, Wuhan, China, 12-14 October 2017-
dc.identifier.citation第十八次全国病毒性肝炎及肝病学术会议暨2017年中华医学会感染病学分会年会、中华医学会肝病学分会年会, 中国, 湖北省,武汉市, 2017年10月12-14日-
dc.identifier.urihttp://hdl.handle.net/10722/253581-
dc.languageeng-
dc.relation.ispartofChinese Infectious Disease and Hepatology Conference-
dc.relation.ispartof第十八次全国病毒性肝炎及肝病学术会议暨2017年中华医学会感染病学分会年会、中华医学会肝病学分会年会, 中国, 湖北省,武汉市, 2017年10月12-14日-
dc.titleTenofovir alafenamide (TAF) compared with Tenofovir Dispoproxil Fumarate (TDF) in patients with chronic HBV: week 96 efficacy and safety results in Chinese patients enrolled in 2 overseas phase 3 studies-
dc.title磷丙替诺福韦（TAF）和富马酸替诺福韦二吡呋酯（TDF）用于慢性HBV患者的疗效比较：纳入2项海外3期研究的华裔患者治疗96周的疗效-
dc.typeConference_Paper-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.hkuros285072-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats